Atlas Trials

Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States

Clinical trial NCT01873417 · COMPLETED

Trial details

NCT number
NCT01873417
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Relapsing Forms of Multiple Sclerosis
Start date
2013-05-01
Primary completion
2013-11-01
Enrollment
237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.